| Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) (NCT00904345) | University of Michigan Rogel Cancer Center | 2009-04-01 |
| Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer (NCT00891904) | Roswell Park Cancer Institute | 2009-04-01 |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... (NCT00924092) | National Cancer Institute (NCI) | 2009-03-13 |
| Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer (NCT00858663) | Memorial Sloan Kettering Cancer Center | 2009-03-01 |
| A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer (NCT00735826) | Dartmouth-Hitchcock Medical Center | 2009-03-01 |
| Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study (NCT00686465) | Ontario Clinical Oncology Group (OCOG) | 2009-03-01 |
| Resistance Training and Physical Functioning in Head and Neck Cancer Patients (NCT01332682) | University of Alabama at Birmingham | 2009-03-01 |
| Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea (NCT01075828) | Merck KGaA, Darmstadt, Germany | 2009-03-01 |
| Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced Xerostomia (NCT00862550) | M.D. Anderson Cancer Center | 2009-03-01 |
| Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer (NCT00851877) | University of Texas Southwestern Medical Center | 2009-03-01 |
| Functional Imaging in HNC Undergoing Chemoradiation (NCT00837980) | Royal Marsden NHS Foundation Trust | 2009-02-01 |
| A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation (NCT00847509) | Siemens Molecular Imaging | 2009-02-01 |
| A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06) (NCT00832559) | Viralytics | 2009-01-27 |
| The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound (NCT00813631) | National Taiwan University Hospital | 2009-01-01 |
| A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma (NCT00872404) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2009-01-01 |
| A Study Using Cone Beam CT for Head and Neck Cancer (NCT01661062) | University of Michigan Rogel Cancer Center | 2009-01-01 |
| Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer (NCT00851253) | Boston Medical Center | 2009-01-01 |
| Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 (NCT00968656) | Washington University School of Medicine | 2009-01-01 |
| Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family (NCT00779389) | University of Pittsburgh | 2009-01-01 |
| Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors (NCT00978081) | Abramson Cancer Center at Penn Medicine | 2009-01-01 |
| Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer (NCT01843673) | Virginia Commonwealth University | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer (NCT00820248) | NCIC Clinical Trials Group | 2008-12-30 |
| Spousal Support in Head and Neck Cancer (NCT00824252) | M.D. Anderson Cancer Center | 2008-12-08 |
| Nurse-led Follow-up Care for Head and Neck Cancer Patients (NCT01167179) | Radboud University Medical Center | 2008-12-01 |
| Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma (NCT00855881) | Mackay Memorial Hospital | 2008-12-01 |
| Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer (NCT00824174) | M.D. Anderson Cancer Center | 2008-12-01 |
| TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer (NCT00774319) | Radboud University Medical Center | 2008-12-01 |
| Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT00833261) | University of Texas Southwestern Medical Center | 2008-12-01 |
| Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers (NCT00738751) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer (NCT00720083) | Radiation Therapy Oncology Group | 2008-11-01 |
| TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer (NCT00765011) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2008-10-01 |
| Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery (NCT01418118) | Oxford University Hospitals NHS Trust | 2008-10-01 |
| MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer (NCT00984074) | Abramson Cancer Center at Penn Medicine | 2008-10-01 |
| Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy (NCT00790322) | Biotec Pharmacon ASA | 2008-10-01 |
| Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 (NCT01015963) | Alliance for Clinical Trials in Oncology | 2008-10-01 |
| Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer (NCT01645748) | Chonnam National University Hospital | 2008-10-01 |
| Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00721513) | Wake Forest University Health Sciences | 2008-09-01 |
| Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer (NCT00756951) | SciClone Pharmaceuticals | 2008-09-01 |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer (NCT00656513) | Radiation Therapy Oncology Group | 2008-09-01 |
| S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00937417) | SWOG Cancer Research Network | 2008-09-01 |
| 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx (NCT00757549) | Mayo Clinic | 2008-09-01 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy (NCT00707655) | Genmab | 2008-09-01 |
| Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer (NCT00750555) | Geisinger Clinic | 2008-09-01 |
| Magnesium Sulphate and Rocuronium in Patients Over 60 (NCT01804205) | Pedro Rotava | 2008-09-01 |
| Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx (NCT00843635) | Donald T. Weed | 2008-09-01 |
| Adherence to Swallowing Exercises in Head and Neck Cancer (NCT00761397) | M.D. Anderson Cancer Center | 2008-08-29 |
| Validation of a Screening Tool in Geriatric Oncology (NCT00963911) | Institut Bergonié | 2008-08-05 |
| Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors (NCT01216800) | Institute of Cancer Research, United Kingdom | 2008-08-01 |
| Creation of the BioBank, Early Detection and Discovery Biomarkers (NCT00901680) | Corewell Health East | 2008-08-01 |
| Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors (NCT01137162) | Stanford University | 2008-08-01 |
| STAT3 DECOY in Head and Neck Cancer (NCT00696176) | University of Pittsburgh | 2008-08-01 |
| Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer (NCT00791141) | Heinrich-Heine University, Duesseldorf | 2008-08-01 |
| Phase II Study of TAS-106 to Treat Head and Neck Cancer (NCT00737360) | Taiho Pharmaceutical Co., Ltd. | 2008-08-01 |
| Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00898911) | ECOG-ACRIN Cancer Research Group | 2008-07-08 |
| TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. (NCT00716391) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2008-07-07 |
| Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas. (NCT00782691) | Radboud University Medical Center | 2008-07-01 |
| Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery (NCT00714649) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2008-07-01 |
| Hyperimmune Colostrum and Oral Mucositis (NCT00699569) | Tel-Aviv Sourasky Medical Center | 2008-07-01 |
| Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer (NCT00690872) | National Cancer Centre, Singapore | 2008-07-01 |
| A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer (NCT00615420) | British Columbia Cancer Agency | 2008-07-01 |
| Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer (NCT00713219) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer (NCT00731380) | University Health Network, Toronto | 2008-07-01 |
| Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer (NCT00963326) | Centre Oscar Lambret | 2008-06-01 |
| Head & Neck Cancer Survivorship: Physical and Functional Status (NCT00751816) | Vanderbilt University | 2008-06-01 |
| Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer (NCT00840814) | Vanderbilt University | 2008-05-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer (NCT01812486) | Universitaire Ziekenhuizen KU Leuven | 2008-05-01 |
| Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer (NCT00702481) | National Cancer Centre, Singapore | 2008-04-28 |
| Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx (NCT00675233) | Roswell Park Cancer Institute | 2008-04-25 |
| Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study) (NCT00756795) | University of Nebraska | 2008-04-24 |
| Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema (NCT00828516) | East and North Hertfordshire NHS Trust | 2008-04-01 |
| Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck (NCT00848042) | Nanospectra Biosciences, Inc. | 2008-04-01 |
| Sexual Behavior in Head and Neck Cancer Patients (NCT00662662) | M.D. Anderson Cancer Center | 2008-04-01 |
| Chemoradiation Treatment for Head and Neck Cancer (NCT00704639) | Trans Tasman Radiation Oncology Group | 2008-04-01 |
| Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer (NCT00899704) | Alliance for Clinical Trials in Oncology | 2008-03-01 |
| Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer (NCT00573989) | Wake Forest University Health Sciences | 2008-03-01 |
| Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery (NCT00601913) | Wake Forest University Health Sciences | 2008-03-01 |
| Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck (NCT00617734) | Eli Lilly and Company | 2008-03-01 |
| Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer (NCT00868491) | Institute of Oncology Ljubljana | 2008-03-01 |
| Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer (NCT00875849) | Centre Antoine Lacassagne | 2008-03-01 |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer (NCT01445405) | National Cancer Institute (NCI) | 2008-02-05 |
| Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer (NCT00665392) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2008-02-01 |
| Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot (NCT03010553) | Gustave Roussy, Cancer Campus, Grand Paris | 2008-02-01 |
| Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy (NCT00536952) | Northwestern University | 2008-02-01 |
| Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery (NCT00646659) | European Organisation for Research and Treatment of Cancer - EORTC | 2008-02-01 |
| Acute and Longlasting Side Effects Caused by Radiotherapy in the Head and Neck Area (NCT00995319) | Norwegian University of Science and Technology | 2008-01-01 |
| An Exploratory, Open Label, Single Center Study of [F-18]HX4 (NCT00606424) | Siemens Molecular Imaging | 2008-01-01 |
| Zalutumumab in Non-curable Patients With SCCHN (NCT00542308) | Genmab | 2008-01-01 |
| Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer (NCT00973947) | Cancer Trials Ireland | 2008-01-01 |
| Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer (NCT00608205) | Case Comprehensive Cancer Center | 2008-01-01 |
| Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer (NCT00566540) | Ohio State University Comprehensive Cancer Center | 2007-12-11 |
| Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use (NCT00799669) | M.D. Anderson Cancer Center | 2007-12-05 |
| Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study (NCT00610415) | Stanford University | 2007-12-01 |
| UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer (NCT00570232) | University of Alabama at Birmingham | 2007-12-01 |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking (NCT00666978) | Lisa Sanderson Cox, PhD | 2007-12-01 |
| EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer (NCT00574860) | Endo USA Inc., a Keenova Therapeutics Company | 2007-12-01 |
| Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck (NCT00720304) | Case Comprehensive Cancer Center | 2007-11-19 |
| Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer (NCT00589186) | National Cancer Centre, Singapore | 2007-11-01 |